Grenfell-Gardner Jason

Avg. Two Year Performance

21% Avg. Purchase Return
10% Compound
27% Avg. Sale Return
13% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(1%)7%11%33%21%
Purchase Success Rate2 of 53 of 52 of 54 of 52 of 5
Average Sale Return6%(6%)7%9%27%
Sale Success Rate2 of 32 of 32 of 32 of 32 of 3
Drugs » Biotechnology

President & CEO, Director:

Holdings: 119.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--